Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 59.40
+0.50 (0.85%)
Dec 12, 2025, 3:59 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 21.68 billion as of December 12, 2025. Its market cap has increased by 65.35% in one year.
Market Cap
21.68B
Enterprise Value
21.75B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
59.40
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 21.68B, an increase of 185.70%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 21.68B | 54.06% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | 8.50B | 39.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |